These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19797556)

  • 61. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.
    Favia G; Pilolli GP; Maiorano E
    Bone; 2009 Sep; 45(3):406-13. PubMed ID: 19450715
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
    Landesberg R; Wilson T; Grbic JT
    Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    Vahtsevanos K; Kyrgidis A; Verrou E; Katodritou E; Triaridis S; Andreadis CG; Boukovinas I; Koloutsos GE; Teleioudis Z; Kitikidou K; Paraskevopoulos P; Zervas K; Antoniades K
    J Clin Oncol; 2009 Nov; 27(32):5356-62. PubMed ID: 19805682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
    Reid IR; Bolland MJ; Grey AB
    Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference.
    Bilezikian JP; Grbic JT
    Ann N Y Acad Sci; 2011 Feb; 1218():1-2. PubMed ID: 21291476
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
    Wang EP; Kaban LB; Strewler GJ; Raje N; Troulis MJ
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bisphosphonate-associated osteonecrosis of the jaw: patient care considerations: overview for the orthopaedic nursing healthcare professional.
    Cohen HV
    Orthop Nurs; 2010; 29(3):176-80; quiz 181-2. PubMed ID: 20505486
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap.
    Pautke C; Otto S; Reu S; Kolk A; Ehrenfeld M; Stürzenbaum S; Wolff KD
    Oral Oncol; 2011 May; 47(5):425-9. PubMed ID: 21478047
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
    Raje N; Woo SB; Hande K; Yap JT; Richardson PG; Vallet S; Treister N; Hideshima T; Sheehy N; Chhetri S; Connell B; Xie W; Tai YT; Szot-Barnes A; Tian M; Schlossman RL; Weller E; Munshi NC; Van Den Abbeele AD; Anderson KC
    Clin Cancer Res; 2008 Apr; 14(8):2387-95. PubMed ID: 18413829
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
    Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
    Lee CY; Suzuki JB
    Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases].
    Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca EP; De Moor RJ; Nammour S
    Rev Belge Med Dent (1984); 2009; 64(2):87-95. PubMed ID: 19681350
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Osteonecrosis of the jaws and bisphosphonate therapy.
    Ruggiero SL; Drew SJ
    J Dent Res; 2007 Nov; 86(11):1013-21. PubMed ID: 17959890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.
    Montebugnoli L; Felicetti L; Gissi DB; Pizzigallo A; Pelliccioni GA; Marchetti C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):473-7. PubMed ID: 17482847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.
    Rachner TD; Platzbecker U; Felsenberg D; Hofbauer LC
    Mayo Clin Proc; 2013 Apr; 88(4):418-9. PubMed ID: 23541016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Estilo CL; Van Poznak CH; Wiliams T; Bohle GC; Lwin PT; Zhou Q; Riedel ER; Carlson DL; Schoder H; Farooki A; Fornier M; Halpern JL; Tunick SJ; Huryn JM
    Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011).
    Marcuzzi A; Zanin V; Crovella S; Pontillo A
    Oral Oncol; 2011 May; 47(5):436-7; author reply 438. PubMed ID: 21411362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.